Unique ID issued by UMIN | UMIN000024738 |
---|---|
Receipt number | R000028462 |
Scientific Title | The study of algorithm for insulin dose after the change to insulin glargine U300 (LANTUS-XR) for type 2 diabetic patients with poor glucose control under insulin therapy. |
Date of disclosure of the study information | 2016/11/07 |
Last modified on | 2019/05/15 20:31:47 |
The study of algorithm for insulin dose after the change to insulin glargine U300 (LANTUS-XR) for type 2 diabetic patients with poor glucose control under insulin therapy.
ISLAND STUDY
The study of algorithm for insulin dose after the change to insulin glargine U300 (LANTUS-XR) for type 2 diabetic patients with poor glucose control under insulin therapy.
ISLAND STUDY
Japan |
Type 2 diabetes mellitus
Medicine in general | Endocrinology and Metabolism | Adult |
Others
NO
To assess usefulness of self-titration based on self-monitoring blood glucose.
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
The percentage of cases where the absolute value improved by 1% or more or 10% or more from baseline HbA1c
fasting glucose level, weight change, Insulin dose
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Medicine |
Self-titration group
The attending physician changed Lantus to U300 without changing insulin dose at fisrt. Each patient in this group was instructed on SMBG and the algorithm of this study. The algorithm of this study as follows: each patient measured fasting blood glucose every day. Patient aged 65 years and older increase their dose of U300 by one Units per day if fasting blood glucose level was 110 mg/dl or higher 3 consecutive days, Patient aged less than 65 years increase their dose of U300 by one Units per day if fasting blood glucose level was 100 mg/dl or higher 3 consecutive days.
Physician lead group
The attending physician changed Lantus to U300 without changing insulin dose. Each patients used self-monitoring of blood glucose to estimate their glycemic status. Each patient in this group injected same dose of insulin U300 until the next hospital visit. The physician changed the U300 dose every one month visit using .their SMBG data and HbA1c
10 | years-old | <= |
100 | years-old | > |
Male and Female
Type 2 diabetes mellitus undertreatment for LUNTUS
Dementia
Type 1 diabetes mellitus
Patient with GAD antibody
Hypoglycemia
Hypersensitivity to LANTUS
Pregnant
Severe liver dysfunction
Severe renal dysfunction
100
1st name | Tetsuji |
Middle name | |
Last name | Niiya |
Matsuyama shimin hospital
Internal Medicine
790-0067
Otemachi, Matsuyama, Ehime
81-89-943-1151
t.niiya@matsuyama-shimin-hsp.or.jp
1st name | Tetsuji |
Middle name | |
Last name | Niiya |
Matsuyama shimin Hospital
Internal Medicine
790-0067
Otemachi, Matsuyama, Ehime
81-89-943-1151
t.niiya@matsuyama-shimin-hsp.or.jp
Matsuyama shimin hospital
Matsuyama shimin hospital
Self funding
Matsuyama Shimin Hospital
6-6-5, 2tyoume, Ootemachi, Matsuyama
089-943-1151
t.niiya@matsuyama-shimin-hsp.or.jp
NO
2016 | Year | 11 | Month | 07 | Day |
Unpublished
Terminated
2016 | Year | 11 | Month | 01 | Day |
2016 | Year | 11 | Month | 07 | Day |
2016 | Year | 11 | Month | 07 | Day |
2019 | Year | 05 | Month | 15 | Day |
2016 | Year | 11 | Month | 07 | Day |
2019 | Year | 05 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028462